SAN
DIEGO, Dec. 19, 2023 /PRNewswire/ -- Illumina,
Inc. (NASDAQ: ILMN) today announced that its executives will be
speaking at the following investor conference:
- 42nd Annual J.P. Morgan Healthcare Conference on
January 9, 2024
Presentation at 9:00am Pacific Time
(12:00pm Eastern Time) immediately
followed by a Q&A Session to begin at approximately
9:20am Pacific Time (12:20pm Eastern Time)
The webcast can be accessed through the Investor Info section of
Illumina's website at investor.illumina.com. A replay will be
posted on Illumina's website after the event and will be available
for at least 30 days following.
About Illumina
Illumina is improving human health by
unlocking the power of the genome. In 2023, we celebrate 25 years
of innovation, which has established us as a global leader in DNA
sequencing and array-based technologies, serving customers in the
research, clinical and applied markets. Our products are used for
applications in the life sciences, oncology, reproductive health,
agriculture and other emerging segments. To learn more, visit
www.illumina.com and connect with us on X (Twitter),
Facebook, LinkedIn, Instagram, TikTok and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
David McAlpine
+1.347.327.1336
pr@illumina.com
View original
content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-302019450.html
SOURCE Illumina, Inc.